Related references
Note: Only part of the references are listed.Prognostic Roles of Neutrophil-to-Lymphocyte Ratio and Stromal Tumor-Infiltrating Lymphocytes and Their Relationship in Locally Advanced Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy
Xue Dong et al.
BREAST CARE (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2-) Breast Cancer
Yuanping Hu et al.
CLINICAL BREAST CANCER (2020)
Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment
Wendy Munoz-Montano et al.
CLINICAL BREAST CANCER (2020)
Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis
Melinda L. Telli et al.
CLINICAL CANCER RESEARCH (2020)
Can the Neutrophil to Lymphocyte Ratio Predict Complete Pathologic Response to Neoadjuvant Breast Cancer Treatment? A Systematic Review and Meta-analysis
Carolyn Cullinane et al.
CLINICAL BREAST CANCER (2020)
The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients
Jiaqiang Dan et al.
BREAST CANCER (2020)
Correlation between peripheral blood inflammatory indicators and pathologic complete response to neoadjuvant chemotherapy in locally advanced breast cancer patients
Tulay Eren et al.
MEDICINE (2020)
The prevalence of cancer associated systemic inflammation: Implications of prognostic studies using the Glasgow Prognostic Score
Ross D. Dolan et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study
Francesco Schettini et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Association of Pathologic Complete Response with Long-Term Survival Outcomes in Triple-Negative Breast Cancer: A Meta-Analysis
Min Huang et al.
CANCER RESEARCH (2020)
Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer: A Review
Weilin Xu et al.
ONCOTARGETS AND THERAPY (2020)
Prognostic value of neutrophil-to-lymphocyte ratio in human epidermal growth factor receptor 2-negative breast cancer patients who received neoadjuvant chemotherapy
Soong June Bae et al.
SCIENTIFIC REPORTS (2020)
The complexity of neutrophils in health and disease: Focus on cancer
Silvia Carnevale et al.
SEMINARS IN IMMUNOLOGY (2020)
Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers
Tina Gruosso et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients
Vincenzo Graziano et al.
BREAST (2019)
Prognostic Role and Clinical Association of Tumor-Infiltrating Lymphocyte, Programmed Death Ligand-1 Expression with Neutrophil-Lymphocyte Ratio in Locally Advanced Triple-Negative Breast Cancer
Jieun Lee et al.
CANCER RESEARCH AND TREATMENT (2019)
Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients
B. Losada et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Prognostic role of high neutrophil-to-lymphocyte ratio in breast cancer patients receiving neoadjuvant chemotherapy Meta-analysis
Ling Bo Xue et al.
MEDICINE (2019)
Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis
Bo Li et al.
CLINICA CHIMICA ACTA (2018)
Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer
S. Chae et al.
CURRENT ONCOLOGY (2018)
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Carsten Denkert et al.
LANCET ONCOLOGY (2018)
Peripheral inflammation/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapy
Yi Qian et al.
ONCOTARGETS AND THERAPY (2018)
The value of neutrophil-to-lymphocyte ratio for response and prognostic effect of neoadjuvant chemotherapy in solid tumors: A systematic review and meta-analysis
Xuan Li et al.
JOURNAL OF CANCER (2018)
Neutrophil to lymphocyte ratio is a prognostic factor for disease free survival in patients with breast cancer underwent curative resection
Sheng-Kai Geng et al.
MEDICINE (2018)
Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy
Yuyong Li et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer
Wataru Goto et al.
BMC CANCER (2018)
Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy
C. Marin Hernandez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer
Yuka Asano et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study
Yi Chen et al.
BMC CANCER (2016)
Clinical significance of tumor-infiltrating lymphocytes in breast cancer
Sasha E. Stanton et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
Seth B. Coffelt et al.
NATURE (2015)
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Cancer-related inflammation and treatment effectiveness
Connie I. Diakos et al.
LANCET ONCOLOGY (2014)
Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting
Young Wha Koh et al.
TUMOR BIOLOGY (2014)
Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
Hiroko Masuda et al.
CLINICAL CANCER RESEARCH (2013)
Pathological Complete Response and Accelerated Drug Approval in Early Breast Cancer
Tatiana M. Prowell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Inter-rater and test-retest reliability of quality assessments by novice student raters using the Jadad and Newcastle-Ottawa Scales
Mark Oremus et al.
BMJ OPEN (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer
Kristine H. Allin et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2011)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Share Paper
